Companies: 10,795·Total market cap: $144.5T
Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc.

JSPRNASDAQHealthcare● Active
$0.45
$-0.01(-3.03%)
Market Cap$7375416
P/E Ratio—
52W High$7.19
52W Low$0.43
Overview

Jasper Therapeutics, Inc. (JSPR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001788028 · JSPR · NASDAQ · as of Jun 9, 2026

Filing snapshot

441
Total Filings
8-K
Latest Form
2026-06-01
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001788028 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001213900-26-050178
Primary Document
ea0287356-10ka1_jasper.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001788028 · Accession 0001213900-26-050178

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2026-05-14
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2026-06-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
CURRENT REPORT
2026-06-01
View
8-KCurrent Report
CURRENT REPORT
2026-05-21
View
10-QQuarterly Report
QUARTERLY REPORT
2026-05-14
View
8-KCurrent Report
CURRENT REPORT
2026-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-08
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-08
View
10-K/AAnnual Report (Amended)
AMENDMENT NO. 1 TO FORM 10-K
2026-04-30
View
8-KCurrent Report
CURRENT REPORT
2026-03-30
View
10-KAnnual Report
ANNUAL REPORT
2026-03-30
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-25
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-02-18
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-12
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-11
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-26
View
Showing 1–15 of 315 filingsForm 4 / 144 hidden· 441 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001788028  |  Exchange: NASDAQ · Healthcare

Jasper Therapeutics, Inc. (NASDAQ: JSPR) has submitted 441 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001788028, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Jasper Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Jasper Therapeutics, Inc. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical JSPR 10-K annual reports are available from 2019 through 2026.

Investors researching Jasper Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
QTTB SEC Filings →VRCA SEC Filings →GBIO SEC Filings →MURA SEC Filings →BTAI SEC Filings →SABS SEC Filings →BOLD SEC Filings →CELU SEC Filings →
→ JSPR Financials→ JSPR Earnings→ JSPR Insider Trades

Frequently Asked Questions

JSPR SEC Filings · 8 questions

Jasper Therapeutics, Inc. (JSPR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 441 filings and access original documents at no cost. Jasper Therapeutics, Inc.'s CIK is 0001788028.

JSPR SEC filingsJasper Therapeutics, Inc. SEC documentsfind JSPR 10-K